Portfolio Thuja Capital Healthcare Seed Fund I

Company: Mellon Medical B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2013
Status: Active

Mellon Medical B.V. is a Dutch specialist medical technology company that develops and commercializes innovative surgical instruments to allow for single-handed stitching.

Company: Cristal Therapeutics - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2012
Status: Active

Cristal Therapeutics (formerly known as Cristal Delivery) is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies, registered as CriPec®.  Cristal Delivery’s mission is optimise the therapeutic performance of drugs and thereby improve patient care.

Company: Fabpulous B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2009
Status: Active

Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.

Company: Cavadis B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2009
Status: Active

Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.

Company: argenx b.v. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2008
Status: Realized

argenx is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio.

Company: Hemics B.V. - Visit website
Fund: Thuja Capital Healthcare Seed Fund I
Year: 2011
Status: Active

Hemics is a medical technology company (Philips spin-out), developing an imaging apparatus to measure and monitor rheumatoid arthritis disease activity in the joints of the hands.

Company: DCPrime B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2010
Status: Realized

DCPrime is a biotech company with a proprietary allogeneic dendritic cell line as a platform to derive and develop the next generation therapeutic dendritic cancer vaccines.

Company: NightBalance B.V. - Visit website
Fund: Thuja Capital Healthcare Fund I
Year: 2011
Status: Active

NightBalance is a medtech company developing and commercializing a patient-friendly device to treat positional sleep apnea.